Related Experiment Video

Updated: Aug 13, 2026

Spheroid Assay to Measure TGF-β-induced Invasion
09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to

I Y Kim1, H J Ahn, D J Zelner

  • 1Department of Urology, Northwestern University Medical School, Chicago, Illinois 60611, USA.

Cancer Research
|January 1, 1996
PubMed

Insights

Transforming growth factor beta 1 (TGF-beta 1) regulates prostate cancer cell growth via membrane receptors. LNCaP cells lack TGF-beta receptor type I, rendering them insensitive to TGF-beta 1, unlike PC3 and DU145 cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Transforming growth factor beta 1 (TGF-beta 1) is implicated in prostate cancer cell growth regulation.
  • TGF-beta 1 signaling relies on cell surface receptor complexes.
  • Understanding receptor expression is crucial for TGF-beta 1's role in prostate cancer.

Purpose of the Study:

  • To correlate TGF-beta 1 sensitivity with TGF-beta receptor expression in prostate cancer cell lines.
  • To investigate the molecular basis for differential TGF-beta 1 response in PC3, DU145, and LNCaP cells.

Main Methods:

  • Western blot and reverse transcriptase-PCR to assess TGF-beta receptor type I and II expression.
  • Southern blot analysis to detect genetic alterations in the type I receptor gene.
  • Transient transfection of LNCaP cells with T beta R-I cDNA.

Main Results:

  • PC3 and DU145 cells, sensitive to TGF-beta 1, expressed both receptor types.
  • LNCaP cells, insensitive to TGF-beta 1, expressed type II but lacked type I receptor.
  • Southern blot revealed a genetic alteration in the type I receptor gene in LNCaP cells.
  • Restoration of TGF-beta 1 sensitivity in LNCaP cells after transfection with T beta R-I cDNA.

Conclusions:

  • Prostate cancer cell sensitivity to TGF-beta 1 is dependent on functional TGF-beta receptor type I expression.
  • LNCaP cells exhibit TGF-beta 1 insensitivity due to a defective type I receptor gene.
  • Targeting TGF-beta receptor pathways may offer therapeutic strategies for prostate cancer.

More Related Videos

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...